Skip to main content

Advertisement

SpringerLink
Log in

Detection and management of renal cell carcinoma in the renal allograft

  • Urology - Original Paper
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Purpose

Tumours of the transplanted kidney represent a rare form of post-transplantation malignancies. An important aspect of the treatment option is whether the transplanted kidney can be saved or not. Aim of our study was the analysis of our allograft tumours.

Methods

In the Budapest Centre, 3,530 kidney transplantations were performed between 1973 and 2012. Retrospective analysis of 9 patients who developed renal cell carcinoma (RCC) in the transplanted kidney was done.

Results

Mean age of recipients was 45.3 ± 13.4 years at the time of transplantation and 57.0 ± 11.6 years at the time of tumour detection. Mean age of their donors was 43.5 ± 11.5 years. Mean time from transplantation to tumour diagnosis was 134.6 ± 40.8 months. Seven RCC were stage pT1a, 1 was stage pT1b and 1 was pT3a. Eight patients had stage I. (pT1a-b, N0, M0) and 1 patient had stage IV. (pT3a, N1, M1) disease. Histological types were clear cell (n = 6), papillary (n = 2) and sarcomatoid (n = 1) carcinomas. The tumour growth rate of RCC was 16.7 ± 13.5 mm/year. In 4 cases, transplant nephrectomy was performed; 5 cases had percutaneous radiofrequency ablation (RFA). Ablative therapy had no influence on renal graft function. Six patients (including 5 patients who were treated with RFA) are still alive and tumour-free; 3 patients died.

Conclusions

According to our observation, we can state that RCC of the kidney allograft diagnosed at an early stage can be successfully treated with RFA instead of graft removal. A longer follow-up is needed to assess the effectivity of the RFA treatment in these cases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Cheung CY, Lam MF, Lee KC et al (2011) Renal cell carcinoma of native kidney in Chinese renal transplant recipients: a report of 12 cases and a review of the literature. Int Urol Nephrol 43:675–680

    Article  PubMed  Google Scholar 

  2. G Végső, Toronyi É, Hajdu M et al (2011) Renal cell carcinoma of the native kidney: a frequent tumor after kidney transplantation with favorable prognosis in case of early diagnosis. Transplant Proc 43:1261–1263

    Article  Google Scholar 

  3. Ploussard G, Chambade D, Meria P et al (2012) Biopsy-confirmed de novo renal cell carcinoma (RCC) in renal grafts: a single-centre management experience in a 2396 recipient cohort. BJU Int 109:195–199

    Article  PubMed  Google Scholar 

  4. Roupret M, Peraldi MN, Thaunat O et al (2004) Renal cell carcinoma of the grafted kidney: how to improve screening and graft tracking. Transplantation 77:146–148

    Article  PubMed  Google Scholar 

  5. Tsaur I, Obermüller N, Jonas D et al (2011) De novo renal cell carcinoma of native and graft kidneys in renal transplant recipients. BJU Int 108:229–234

    Article  PubMed  Google Scholar 

  6. Barama A, St-Louis G, Nicolet V et al (2005) Renal cell carcinoma in kidney allografts: a case series from a single center. Am J Transplant 5:3015–3018

    Article  PubMed  CAS  Google Scholar 

  7. Penn I (2000) Cancers in renal transplant recipients. Adv Ren Replace Ther 7:147–156

    PubMed  CAS  Google Scholar 

  8. Chow WH, Dong LM, Devesa SS (2010) Epidemiology and risk factors for kidney cancer. Nat Rev Urol 7:245–257

    Article  PubMed  Google Scholar 

  9. Sassa N, Hattori R, Tsuzuki T et al (2011) Renal cell carcinomas in haemodialysis patients: does haemodialysis duration influence pathological cell types and prognosis? Nephrol Dial Transplant 26:1677–1682

    Article  PubMed  Google Scholar 

  10. Zavos G, Kakisis J, Bokos J et al (2007) De novo renal cell carcinoma in a kidney allograft 13 years after transplantation: a case report and review of the literature. Urol Int 78:283–285

    Article  PubMed  Google Scholar 

  11. Heinz-Per G, Helbich T, Nottling B et al (1994) Renal cell carcinoma in an allograft kidney transplant. Transplantation 57:475–478

    Article  Google Scholar 

  12. Campbell SC, Novick AC, Belldegrun A et al (2009) Guideline for management of the clinical T1 renal mass. J Urol 182:1271–1279

    Article  PubMed  Google Scholar 

  13. Kaouk JH, Spana G, Hillyer SP et al (2011) Robotic-assisted laparoscopic partial nephrectomy for a 7 cm mass in renal allograft. Am J Transplant 11:2242–2246

    Article  PubMed  CAS  Google Scholar 

  14. Cornelis F, Buy X, André M et al (2011) De novo renal tumors arising in kidney transplants: midterm outcome after percutaneous thermal ablation. Radiology 260:900–907

    Article  PubMed  Google Scholar 

  15. Manuelli M, De Luca L, Iaria G et al (2010) Conversion to rapamycin immunosuppression for malignancy after kidney transplantation. Transplant Proc 42:1314–1316

    Article  PubMed  CAS  Google Scholar 

  16. Pal SK, Figlin RA (2010) Treatment options in metastatic renal cell carcinoma: focus on mTOR inhibitors. Clin Med Insights Oncol 4:43–53

    PubMed  CAS  Google Scholar 

  17. Penn I (1995) Primary kidney tumors before and after renal transplantation. Transplantation 59:480–485

    PubMed  CAS  Google Scholar 

  18. Neipp M, Schwarz A, Pertschy S et al (2006) Accidental transplantation of a kidney with a cystic renal cell carcinoma following living donation: management and 1 year follow-up. Clin Transplant 20:147–150

    Article  PubMed  Google Scholar 

  19. Buell JF, Hanaway MJ, Thomas M et al (2005) Donor kidney with small renal cell cancers: can they be transplanted? Transplant Proc 37:581–582

    Article  PubMed  CAS  Google Scholar 

  20. Nalesnik MA, Woodle ES, DiMaio JM et al (2011) Donor-transmitted malignancies in organ transplantation: assessment of clinical risk. Am J Transplant 11:1140–1147

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Transplantation and Surgery, Semmelweis University, Baross u. 23, 1082, Budapest, Hungary

    Gyula Végső, Éva Toronyi, Pál Ákos Deák, Attila Doros & Róbert Miklós Langer

Authors
  1. Gyula Végső
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Éva Toronyi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Pál Ákos Deák
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Attila Doros
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Róbert Miklós Langer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gyula Végső.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Végső, G., Toronyi, É., Deák, P.Á. et al. Detection and management of renal cell carcinoma in the renal allograft. Int Urol Nephrol 45, 93–98 (2013). https://doi.org/10.1007/s11255-012-0274-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-012-0274-1

Keywords

Search

Navigation